/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749977098&Signature=hxx6mJJID~uvcMetNzCBvLY8K97ox92xV371syRdYvaa41jef~U-Hm~m-emo1O5bBFV8TSFGZU0N8W9rCwvZffGkEGeNL8RX2EmjN1KclAwxrEe75aFc2-tsQXj0h0wtgSQi5Pvl-IcxiTH0SZd1Nl-R28ufuMULtD4akE~f7CUrK5kPHOmI7kcupr05LOab2ku8mfG-srn1MnspeMAZ38qIRvW6OoeCaHH20LjmYq~fJ69HrlIjl92igj6YE5Q7ilVpL5LBbWhV6xYoxRT1PsXZgBsK9edX3RFEV8vJGc4tS3EjVtUQmOxIOdVlrLezR0~vt64xs41qsJuJO9sV0g__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Lifecare ASA | Norway | LIFE | |
|
Lineage Cell Therapeutics Inc. | Israel | LCTX | |
|
Lipidor AB | Sweden | LIPI | |
|
Lipigon Pharmaceuticals AB | Sweden | LPGO | |
|
Lipum AB | Sweden | LIPUM | |
|
Lonza Group AG | Switzerland | LONN | |
|
LYSOGENE | France | LYS | |
|
Lytix Biopharma AS | Norway | LYTIX | |
|
MaaT Pharma | France | MAAT | |
|
Mabion S.A. | Poland | MAB |